"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Allergy to any component of Tuberculin Purified Protein Derivative (Mantoux) - TUBERSOL (tuberculin purified protein) ®, (see components listed in DESCRIPTION) or an allergic reaction to a previous test of TUBERSOL (tuberculin purified protein) ® are contraindications to the use of TUBERSOL (tuberculin purified protein) ®.
TUBERSOL (tuberculin purified protein) ® should not be administered to persons who previously experienced a severe reaction (eg. vesiculation, ulceration or necrosis) because of the severity of reactions that may occur at the test site.
Last reviewed on RxList: 1/30/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Tubersol Information
Report Problems to the Food and Drug Administration
Find out what women really need.